Blood Transfusion Diagnostics
Blood Transfusion Diagnostics Market Forecasts to 2030 - Global Analysis By Product (Hemoglobinometers, Instruments, Plasma, Reagents & kits and Other Products), Application (Disease Screening, Blood Grouping and Other Applications), End User (Diagnostic Laboratories, Hospitals and Other End Users) and By Geography
According to Stratistics MRC, the Global Blood Transfusion Diagnostics Market is accounted for $4.8 billion in 2023 and is expected to reach $8.5 billion by 2030 growing at a CAGR of 8.5% during the forecast period. This market serves a critical role in ensuring the safety and efficacy of blood transfusions by detecting infectious diseases, identifying blood groups, and assessing compatibility between donors and recipients. These diagnostics help identify potential pathogens such as HIV, hepatitis B and C, and syphilis, reducing the risk of transfusion-transmitted infections. Additionally, blood typing and crossmatching tests ensure compatibility between donor and recipient blood, minimizing the likelihood of adverse reactions during transfusions.
According to an article published by Medscape on March 2022, it was reported that the prevalence of Hemophilia A is 20.6 cases per 100,000 males in the United States. According to an article published by the Canadian Hemophilia Society (CHS) in February 2022, it was reported that the total number of Canadian suffering from Hemophilia A and B is estimated to be 3,100.
Market Dynamics:
Driver:
Rise in blood donor screening programs
With an increasing emphasis on public health and safety standards, blood donor screening programs have become more widespread, aiming to detect infectious diseases and other health conditions that could compromise the integrity of donated blood. These screening programs employ advanced diagnostic technologies such as nucleic acid testing (NAT), serological testing, and immunoassays to identify potential risks associated with donated blood, thus minimizing the chances of transfusion-transmitted infections.
Restraint:
High cost of equipment and tests
Blood transfusion diagnostics rely heavily on specialized equipment and sophisticated tests to ensure the safety and compatibility of donated blood for transfusion. These tools, ranging from automated analyzers to reagents and consumables, incur substantial expenses in procurement and maintenance. The complexity of diagnostic procedures necessitates skilled personnel for operation and interpretation, further adding to the overall costs. However, for healthcare facilities, especially in resource-constrained settings or developing countries, the financial burden of investing in such equipment and conducting tests can be prohibitive, limiting their capacity to offer comprehensive blood transfusion services.
Opportunity:
Increasing healthcare expenditure
As healthcare expenditure rises, there is a corresponding increase in the demand for advanced medical technologies and procedures, including blood transfusion diagnostics. This heightened expenditure allows healthcare facilities to invest in state-of-the-art equipment and diagnostic tools for ensuring the safety and efficacy of blood transfusions. Moreover, as healthcare budgets expand, there's greater focus on improving patient outcomes and reducing the risks associated with blood transfusions, such as transfusion-transmitted infections and adverse reactions.
Threat:
Limited access to advanced technologies
Access to cutting-edge technologies such as nucleic acid amplification tests (NAT), next-generation sequencing (NGS), and automated blood screening systems is essential for accurate and efficient blood transfusion diagnostics. In many regions, especially in developing countries or remote areas, healthcare facilities may lack the infrastructure, resources, or trained personnel to adopt these advanced technologies. As a result, the ability to perform timely and precise blood screening and compatibility testing may be compromised, leading to potential risks such as transfusion-transmitted infections or incompatible blood transfusions.
Covid-19 Impact:
The demand for blood transfusions increased due to Covid-related complications, such as severe respiratory distress or other critical conditions requiring transfusion support. This surge in demand placed pressure on diagnostic services to ensure the safety and compatibility of blood products. On the other hand, pandemic-related restrictions, fear of infection, and disruptions in healthcare services led to reduced blood donations, affecting the blood supply chain. Consequently, blood transfusion diagnostic companies faced challenges in maintaining adequate inventory levels and ensuring timely testing for donated blood, thus intensifying the need for efficient diagnostic solutions and technologies to safeguard transfusion safety amidst the pandemic's uncertainties.
The hemoglobinometers segment is expected to be the largest during the forecast period
Hemoglobinometers segment is expected to be the largest during the forecast period, as it provides quick and reliable assessments of hemoglobin concentration, aiding in the screening of blood donors and ensuring the safety and efficacy of transfusions. By enabling healthcare professionals to rapidly determine hemoglobin levels, hemoglobinometers streamline the blood donation process, reducing the risk of transfusion reactions and improving overall patient outcomes. Additionally, these devices are portable and user-friendly, making them accessible in a variety of healthcare settings, including remote or resource-limited areas.
The blood grouping segment is expected to have the highest CAGR during the forecast period
Blood Grouping segment is expected to have the highest CAGR during the forecast period. Accurate blood typing and crossmatching are critical to prevent adverse reactions during transfusions. With advancements in technology and techniques for blood grouping, such as the introduction of automated systems and molecular testing methods, healthcare facilities can efficiently determine blood types and screen for irregular antibodies. This has significantly reduced the risk of transfusion reactions and improved patient outcomes. Additionally, the increasing demand for blood products due to rising surgical procedures, trauma cases, and chronic diseases has further propelled the regional growth of the Blood Transfusion Diagnostics Market.
Region with largest share:
Over the projected period, the North American area held the largest share due to rising disposable income, improved health infrastructure, rising health consciousness, and favorable reimbursement policies. The American Red Cross estimates that 16 million blood components are transfused annually in the United States. Additionally, this region's high rate of transfusion-transmitted infections and rising blood donation awareness are predicted to fuel market expansion.
Region with highest CAGR:
Due to the rising number of patients with anemia which needs red blood cell transfusion for therapy, Asia Pacific is predicted to experience sustainable growth during the extended period, which is expected to drive up demand for blood transfusion diagnostics. Blood products and entire blood transfusions are in high demand in the area due to the rising prevalence of blood-related conditions such as hemophilia, cancer, thrombocytopenia, etc., and chronic kidney disease (CKD).
Key players in the market
Some of the key players in Blood Transfusion Diagnostics market include Abbott Laboratories, BAG Healthcare GmBH, Bio-Rad Laboratories, Inc, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Grifols S.A., Hologic, Inc, Immucor, Inc, Ortho Clinical Diagnostics and Siemens Healthcare Private Limited.
Key Developments:
In February 2023, MedGenome Labs launched FSHD1 genetic screening test to assess the genetic changes in patients at early stages to facilitate better treatment options. Various government initiatives and approvals are also encouraging players to enter the market.
In November 2022, Werfen entered into an agreement with TPG to acquire Immucor, Inc. Immucor, Inc., is a global company with a wide range of portfolio in transfusion diagnostics products. This will help the company to widen its product range by including the specialized diagnostics solution of Immucor, Inc.
Products Covered:
• Hemoglobinometers
• Instruments
• Plasma
• Reagents & kits
• Other Products
Applications Covered:
• Disease Screening
• Blood Grouping
• Other Applications
End Users Covered:
• Diagnostic Laboratories
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Blood Transfusion Diagnostics Market, By Product
5.1 Introduction
5.2 Hemoglobinometers
5.3 Instruments
5.4 Plasma
5.5 Reagents & kits
5.6 Other Products
6 Global Blood Transfusion Diagnostics Market, By Application
6.1 Introduction
6.2 Disease Screening
6.2.1 Molecular Disease Screening
6.2.2 Serological Disease Screening
6.3 Blood Grouping
6.4 Other Applications
7 Global Blood Transfusion Diagnostics Market, By End User
7.1 Introduction
7.2 Diagnostic Laboratories
7.3 Hospitals
7.4 Other End Users
8 Global Blood Transfusion Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abbott Laboratories
10.2 BAG Healthcare GmBH
10.3 Bio-Rad Laboratories, Inc
10.4 Danaher Corporation
10.5 DiaSorin S.p.A.
10.6 F. Hoffmann-La Roche Ltd
10.7 Grifols S.A.
10.8 Hologic, Inc
10.9 Immucor, Inc
10.10 Ortho Clinical Diagnostics
10.11 Siemens Healthcare Private Limited
List of Tables
1 Global Blood Transfusion Diagnostics Market Outlook, By Region (2021-2030) ($MN)
2 Global Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
3 Global Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
4 Global Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
5 Global Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
6 Global Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
7 Global Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
8 Global Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
9 Global Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
10 Global Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
11 Global Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
12 Global Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
13 Global Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
14 Global Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
15 Global Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
16 Global Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
17 Global Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
18 North America Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
19 North America Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
20 North America Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
21 North America Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
22 North America Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
23 North America Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
24 North America Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
25 North America Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
26 North America Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
27 North America Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
28 North America Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
29 North America Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
30 North America Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
31 North America Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
32 North America Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
33 North America Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
34 North America Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
35 Europe Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
36 Europe Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
37 Europe Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
38 Europe Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
39 Europe Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
40 Europe Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
41 Europe Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
42 Europe Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
43 Europe Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
44 Europe Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
45 Europe Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
46 Europe Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
47 Europe Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
48 Europe Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
49 Europe Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
50 Europe Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
51 Europe Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
52 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
53 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
54 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
55 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
56 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
57 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
58 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
59 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
60 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
61 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
62 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
63 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
64 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
65 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
66 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
67 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
68 Asia Pacific Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
69 South America Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
70 South America Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
71 South America Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
72 South America Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
73 South America Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
74 South America Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
75 South America Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
76 South America Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
77 South America Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
78 South America Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
79 South America Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
80 South America Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
81 South America Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
82 South America Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
83 South America Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
84 South America Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
85 South America Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
86 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Country (2021-2030) ($MN)
87 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Product (2021-2030) ($MN)
88 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Hemoglobinometers (2021-2030) ($MN)
89 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Instruments (2021-2030) ($MN)
90 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Plasma (2021-2030) ($MN)
91 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Reagents & kits (2021-2030) ($MN)
92 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other Products (2021-2030) ($MN)
93 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Application (2021-2030) ($MN)
94 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Disease Screening (2021-2030) ($MN)
95 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Molecular Disease Screening (2021-2030) ($MN)
96 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Serological Disease Screening (2021-2030) ($MN)
97 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Blood Grouping (2021-2030) ($MN)
98 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other Applications (2021-2030) ($MN)
99 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By End User (2021-2030) ($MN)
100 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
101 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Hospitals (2021-2030) ($MN)
102 Middle East & Africa Blood Transfusion Diagnostics Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
